ENG/中
老虎證券
行情
交易
收費
下載
優惠與活動
幫助
TigerAI
學堂
期權訓練營
投資學堂
機構
財富及資產管理人
自營交易機構
介紹經紀商
三方服務商
股權激勵
關於
關於我們
媒體報道
獎項與榮譽
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Trade Technology Pte. Ltd.提供服務
iShares Health Innovation Active ETF
33.21
+0.2458
0.75%
成交量：
534
成交額：
1.77萬
市值：
1,328.43萬
市盈率：
- -
高：
33.21
開：
33.11
低：
33.11
收：
32.97
52周最高：
34.86
52周最低：
25.79
股本：
40.00萬
流通股本：
40.00萬
量比：
0.27
換手率：
0.13%
股息：
0.08
股息率：
0.24%
淨資產收益率：
--
總資產收益率：
--
市淨率：
--
市盈率(LYR):
- -
資料載入中...
總覽
公司
新聞資訊
公告
長風藥業(02652)：ICF001於獲國家藥監局臨床試驗默示許可後擴大適應症範圍
智通财经网
·
08/24
巴克萊因莫德納「具有變革性」的黑色素素瘤疫苗潛力上調其目標價
路透中文
·
08/24
歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態
美股速递
·
08/24
吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌
美股速递
·
08/24
寶濟藥業-B(02659)：KJ015注射液(抗HER2雙特異性抗體皮下製劑)臨床試驗申請獲得美國FDA許可
智通财经
·
08/24
甘李藥業：GZC8072片獲准開展體重控制臨床試驗
智通财经
·
08/24
mRNA疫苗點燃默沙東想象力 「後K藥時代」找到新解法？
每日经济新闻
·
08/23
美股醫療板塊創6月以來最佳周表現，mRNA抗癌疫苗突破提振市場
智通财经
·
08/22
三名科學家在涉及滑石粉研究的誹謗訴訟中勝訴，該訴訟由強生公司提起
路透中文
·
08/22
受癌症疫苗試驗數據影響，Moderna股價連續第三個交易日劇烈震盪
路透中文
·
08/21
默沙東(MRK.US)股價盤中上漲高達3.7%，突破周三創下的歷史高點。
格隆汇
·
08/21
默沙東(MRK)股票8月21日盤中上漲3.41%：真相來了
TradingKey中文
·
08/21
上海萊士：子公司蛋白C臨床試驗申請獲受理
智通财经
·
08/21
華北製藥：金坦公司六價疫苗獲准開展臨床試驗
智通财经
·
08/21
中國生物製藥(01177)：TQF6422注射液「ActRII A/B單抗」臨床試驗申請獲NMPA批准
智通财经
·
08/21
我武生物：貓毛膜劑獲治療用生物製品1類臨床試驗批准
智通财经
·
08/21
百利天恒依據首例給藥臨床試驗確認17億元里程碑收入，BMS尚未打款缺少實質性臨床終點數據
市场资讯
·
08/21
高露潔棕欖印度公司任命Kenvue高管擔任董事總經理兼首席執行官
路透中文
·
08/21
一品紅(300723.SZ)子公司創新藥APH03867片臨床試驗申請獲批
智通财经
·
08/21
一品紅：子公司APH03867片臨床試驗獲批
智通财经
·
08/21
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎證券香港 | 輕鬆買賣美股港股A股/美債/ETF/Crypto/期權期貨","description":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","keywords":"老虎證券,老虎證券開戶,老虎證券香港,老虎證券投資,老虎證券美股,老虎證券登錄,證券開戶,證券公司開戶,股票開戶,香港證券公司,香港證券,證券公司,美股投資平台,小額投資理財,投資app,投資平台,股票買賣,買賣股票平台,炒股app,證券app,新手投資","social":{"ogDescription":"老虎證券香港提供多種優惠: 港股&Crypto 0佣、A股一年0佣、美股期權0佣、IPO抽新股0孖展利息0手續費。美股1美金起投，即時串流報價與多種工具，立即開戶享更多優惠！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrcrest.com/hant/stock/BMED/news?page=10"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"BMED","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","market":"US","secType":"STK","nameCN":"iShares Health Innovation Active ETF","latestPrice":33.2108,"timestamp":1789416000000,"preClose":32.965,"halted":0,"volume":534,"delay":0,"changeRate":0.00745639314424376,"floatShares":400000,"shares":400000,"eps":0,"marketStatus":"盤前交易","change":0.2458,"latestTime":"09-15 04:39:59 EDT","open":33.11,"high":33.2108,"low":33.11,"amount":17725,"amplitude":0.003058,"askPrice":52.8,"askSize":100,"bidPrice":13.36,"bidSize":100,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1789479000000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":33.2108,"sharesOutstanding":360000,"nav":32.890304,"aum":13156121.6,"dividendRate":0.0024,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":33.17,"preClose":33.2108,"latestTime":"16:10 EDT","volume":7,"amount":232.554,"timestamp":1789416603529,"change":-0.0408,"changeRate":-0.001229,"amplitude":0},"volumeRatio":0.27356558498219613,"impliedVol":0.068,"impliedVolPercentile":0.004},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BMED\",,,,,undefined,":{"symbol":"BMED","floatShares":400000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.27356558498219613,"shares":400000,"dividePrice":0.0797,"high":33.2108,"amplitude":0.003058,"preClose":32.965,"low":33.11,"week52Low":25.794,"pbRate":"--","week52High":34.86,"institutionHeld":0,"latestPrice":33.2108,"eps":0,"divideRate":0.0024,"volume":534,"delay":0,"ttmEps":0,"open":33.11,"prevYearClose":30.32,"prevWeekClose":32.965,"prevMonthClose":33.8091,"prevQuarterClose":30.62,"fiveDayClose":34.0304,"twentyDayClose":32.17,"sixtyDayClose":28.4912},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/BMED\",params:#limit:5,,,undefined,":[{"date":"2026-06-15","symbol":"BMED","amount":0.08118,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-15","defaultRemindTime":1781530200000,"name":"iShares Health Innovation Active ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-18","payableDate":"2026-06-15","currency":"USD","dateTimestamp":1781496000000,"payDate":"2026-06-18"},{"date":"2023-12-20","symbol":"BMED","amount":0.007207,"announcedDate":"2023-12-20","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"BlackRock Future Health ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"BMED\",market:\"US\",,,undefined,":[{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.007207,"currency":"USD"},{"executeDate":"2026-06-15","recordDate":"2026-06-15","paymentDate":"2026-06-18","value":0.08118,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"BMED\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BMED\",pageSize:20,pageCount:10,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2661756722","title":"長風藥業(02652)：ICF001於獲國家藥監局臨床試驗默示許可後擴大適應症範圍","url":"https://stock-news.laohu8.com/highlight/detail?id=2661756722","media":"智通财经网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661756722?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:37","pubTimestamp":1787571455,"startTime":"0","endTime":"0","summary":"智通财经APP讯，长风药业 发布公告，集团自主研发的长效吸入干粉候选药物ICF001已获中华人民共和国国家药品监督管理局就间质性肺病开展临床试验的临床试验默示许可。上述许可乃继该产品于2026年3月就肺动脉高压及间质性肺病相关肺高压取得国家药监局临床试验默示许可之后取得。该产品现已获准就涵盖肺血管疾病及进行性纤维化肺病的四项适应症开展临床研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02652","PSYK","MDTX","IBBQ","BMED","BK1191","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661273989","title":"巴克萊因莫德納「具有變革性」的黑色素素瘤疫苗潛力上調其目標價","url":"https://stock-news.laohu8.com/highlight/detail?id=2661273989","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661273989?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:05","pubTimestamp":1787569505,"startTime":"0","endTime":"0","summary":"BUZZ-巴克莱因莫德纳“具有变革性”的黑色素素瘤疫苗潜力上调其目标价8月24日-** 巴克莱将疫苗制造商莫德纳（MRNA.O）的目标价从48美元上调至125美元，维持“中性”评级** 新目标价较该股上周五收盘价仍有13.9%的下行空间** 此次上调目标价发生在莫德纳和默克公司MRK.N联合宣布其共同开发的皮肤癌疫苗晚期临床试验取得 (link) 突破性成果一周之后，该试验表明，实验性疗法Inti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260824:nL4S44L0RI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0106261372.USD","LU2433249047.HKD","LU2125154935.USD","LU0124676726.USD","BK4548","LU0965508806.USD","BK4559","LU1116320901.HKD","SG9999001176.SGD","IYH","IDNA","LU2361045086.USD","SG9999014567.USD","MRK","LU0058720904.USD","LU0266013472.USD","LU2125909593.SGD","IE00BJT1NW94.SGD","LU1989771016.USD","FTXH","IE00BSNM7G36.USD","IE00BJJMRZ35.SGD","LU1093756325.SGD","LU1116320737.USD","FHLC","LU2125909247.SGD","SG9999001440.SGD","LU2461242641.AUD","LU0965509101.SGD","SG9999014542.SGD","LU0477156953.USD","LU2324357040.USD","SG9999002232.USD","SGXZ57979304.SGD","SG9999002224.SGD","LU1061106388.HKD","IE000M9KFDE8.USD","LU1934455863.HKD","LU1430594728.SGD","IE00B1BXHZ80.USD","SG9999015341.SGD","LU1989772840.SGD","LU0070302665.USD","PPH","LU1941712348.USD","LU1201861249.SGD","GDOC","LU0965509010.AUD","LU0320765646.SGD","BK4532","LU0208291251.USD","LU1066051811.HKD","LU1035773651.USD","LU1929549753.HKD","SG9999014559.SGD","BMED","LU0868494708.USD","LU1093756168.USD","IE00BBT3K403.USD","MRNX","MRNA","LU0965509283.SGD","GNOM","LU0130517989.USD","LU0985320562.USD","BK4550","LU2468319806.SGD","HRTS","IXJ","SG9999014575.USD","XLV","LU1585245621.USD","IE00B2B36J28.USD","LU2491050154.USD","IE00BLSP4452.SGD","TRUH","LU1291159041.SGD","LU2023250843.SGD","LU1066053197.SGD","LU0122379950.USD","LU0320765489.SGD","IE00B4R5TH58.HKD","MRNY","IE00BLSP4239.USD","BK4007","IE0002141913.USD","LU1069347547.HKD","LU1983299246.USD","LU2491050071.SGD","LU0432979614.USD","PAWZ","LU2491049909.HKD","LU1934455277.USD","JDOC","LU1037948897.HKD","LU1066051498.USD","LU0265550359.USD","IHE","BK4551","SG9999001176.USD","LU0130102774.USD","RXL","LU2089984988.USD","LU0238689110.USD","LU1057294990.SGD","LU2361044865.SGD","LU0861579265.USD","LU0203347892.USD","LU0689626769.HKD","LU0823416689.USD","IE00BFTCPJ56.SGD","LU0203345920.USD","VHT","LU1699723380.USD","BK4585","LU0980610538.SGD","BK4588","BK4533","LU1066051225.USD","LU1923622614.USD","BK4139","BK4568","LU2361044949.HKD","LGHT","BK4516","LU0868494617.USD","LU1989772923.USD","SG9999013999.USD","IE0009355771.USD","LU1037948541.HKD","LU0859254822.USD","LU1917777945.USD","LU1162221912.USD","LU0098860793.USD","WDNA","LU2360032135.SGD","LU1571399168.USD","LU1974910355.USD","SG9999015358.SGD","LU0289739699.SGD","LU0006306889.USD","BK4534","LU1934455194.USD","LU0234572021.USD","LU1941712264.USD","LU1023059063.AUD","LU0648001328.SGD","LU0942090050.USD","IE00BN8TJ469.HKD","LU2112291526.USD","LU2125154778.USD","LU0211331839.USD","BK4501","LU0265550946.USD","LU2357627491.SGD","LU2023250504.SGD","LU2106854487.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1186632498","title":"歐盟委員會擴大吉利德Trodelvy®在轉移性三陰性乳腺癌一線治療中的應用範圍，覆蓋所有PD-L1狀態","url":"https://stock-news.laohu8.com/highlight/detail?id=1186632498","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1186632498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567559,"startTime":"0","endTime":"0","summary":"欧盟委员会近日作出重要决定，将吉利德科学（Gilead Sciences）旗下重磅药物Trodelvy®的适用范围进一步拓宽。此次调整聚焦于转移性三阴性乳腺癌的一线治疗领域，且不再受限于患者的PD-L1表达状态。这一举措意味着，无论生物标志物检测结果如何，符合条件的患者均有望从该疗法中获益。此举不仅为临床医生提供了更为灵活的用药选择，也标志着Trodelvy®在肿瘤治疗版图中的地位得到显著提升。吉利德科学方面对此表示积极回应，认为该批准将助力满足更多患者未被满足的医疗需求。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0965509283.SGD","LU1839511570.USD","GILD","LU1037948541.HKD","IE0002270589.USD","LU2357627491.SGD","LU2089984988.USD","LU1037948897.HKD","LU0889565916.HKD","BK4532","LU0289739699.SGD","IE00B19Z3B42.SGD","LU0320765992.SGD","LU1023059063.AUD","LU0058720904.USD","LU0823416689.USD","SG9999015945.SGD","LU2087621335.USD","BK4578","BK4585","LU0861579265.USD","TBXU","IE00B3T34201.USD","LU0859254822.USD","BBH","LU1430594728.SGD","LU1934455863.HKD","LU2324357040.USD","BK4139","IE00BSNM7G36.USD","LU0882574055.USD","LU1066051498.USD","LU0234570918.USD","IBBQ","IE00B7SZLL34.SGD","BK4583","BMED","LU2112291526.USD","BK4566","BIB","LU0965508806.USD","LU0965509101.SGD","BK4550","IE00B19Z3581.USD","LU1778281490.HKD","LU1057294990.SGD","LU1934455194.USD","LU1066053197.SGD","IE00BKVL7J92.USD","LU0109394709.USD","LU0965509010.AUD","SG9999015978.USD","LU0114720955.EUR","SG9999015952.SGD","IE00BZ1G4Q59.USD","BK4568","LU1674673428.USD","MEDI","IBB","LU0122379950.USD","BK4588","LU1571399168.USD","LU1585245621.USD","LU1934455277.USD","LU1674673691.USD","LU2468319806.SGD","SG9999015986.USD","TMED","LU1061106388.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1193380081","title":"吉利德科學：歐盟批准Trodelvy聯合Keytruda用於一線PD-L1陽性轉移性三陰性乳腺癌","url":"https://stock-news.laohu8.com/highlight/detail?id=1193380081","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1193380081?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:32","pubTimestamp":1787567533,"startTime":"0","endTime":"0","summary":"吉利德科学公司宣布，欧盟已正式授予其抗体药物偶联物Trodelvy与默沙东的Keytruda联合用药方案的上市许可。这一批准针对的是既往未经治疗的PD-L1阳性转移性三阴性乳腺癌患者群体。此项授权标志着该联合疗法在欧盟地区的临床可及性迈出关键一步，为这类侵袭性强、治疗选择有限的乳腺癌亚型患者提供了新的一线治疗选项。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999015978.USD","IE0002270589.USD","BK4578","LU1430594728.SGD","LU0109394709.USD","LU0289739699.SGD","LU1585245621.USD","LU1934455194.USD","LU2468319806.SGD","SG9999015952.SGD","SG9999015986.USD","BMED","LU2089984988.USD","LU2357627491.SGD","LU1839511570.USD","BIB","IE00BZ1G4Q59.USD","LU0965509010.AUD","LU2112291526.USD","IE00BKVL7J92.USD","LU1037948541.HKD","IE00B19Z3B42.SGD","BK4583","LU1061106388.HKD","LU0234570918.USD","BBH","LU0320765992.SGD","TBXU","LU1934455863.HKD","MEDI","BK4532","LU1934455277.USD","LU1674673428.USD","LU0859254822.USD","LU0882574055.USD","BK4585","LU1066053197.SGD","GILD","IBB","BK4568","TMED","BK4139","IBBQ","IE00B7SZLL34.SGD","LU0889565916.HKD","LU1037948897.HKD","LU0823416689.USD","LU0965509283.SGD","LU1674673691.USD","LU0114720955.EUR","LU1023059063.AUD","LU1066051498.USD","LU0965509101.SGD","LU1571399168.USD","LU1057294990.SGD","IE00BSNM7G36.USD","LU0058720904.USD","BK4550","BK4566","LU1778281490.HKD","LU0122379950.USD","LU0861579265.USD","LU2087621335.USD","LU2324357040.USD","SG9999015945.SGD","IE00B19Z3581.USD","LU0965508806.USD","IE00B3T34201.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661095227","title":"寶濟藥業-B(02659)：KJ015注射液(抗HER2雙特異性抗體皮下製劑)臨床試驗申請獲得美國FDA許可","url":"https://stock-news.laohu8.com/highlight/detail?id=2661095227","media":"智通财经","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661095227?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 18:02","pubTimestamp":1787565773,"startTime":"0","endTime":"0","summary":"智通财经APP讯，宝济药业-B 发布公告，于2026年8月21日，本公司自主研发的KJ015注射液的新药临床试验申请获得美国食品药品监督管理局批准，获准在美国开展临床试验。本公司的临床前研究显示，KJ015相较于传统抗HER2单克隆抗体组合，在临床前阶段的整体疗效有所增强。本公司正内部开发KJ015，并拥有开发及商业化KJ015的全球权利。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1484293.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["IBBQ","PSYK","LABU","IBBJ","MDTX","02659","BMED","BK1161","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661467224","title":"甘李藥業：GZC8072片獲准開展體重控制臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2661467224","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661467224?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 17:04","pubTimestamp":1787562270,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BMED","IBBJ","IBBQ","PSYK","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661243397","title":"mRNA疫苗點燃默沙東想象力 「後K藥時代」找到新解法？","url":"https://stock-news.laohu8.com/highlight/detail?id=2661243397","media":"每日经济新闻","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661243397?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 20:39","pubTimestamp":1787488796,"startTime":"0","endTime":"0","summary":"疫苗公司Moderna（莫德纳）和美国药企默沙东宣布黑色素瘤皮肤癌疫苗IntismeranAutogene（以下简称intismeran）在大型试验中达到目标影响。资本市场反应强烈。莫德纳当日股价大涨近177%，默沙东同步大涨近13%，整个mRNA（信使核糖核酸）板块也随之出现明显行情。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608233850380834.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608233850380834.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["IXJ","MRNY","LU0942090050.USD","IE00B1BXHZ80.USD","IYH","LU0859254822.USD","LU0868494617.USD","LU1989772840.SGD","LU2106854487.HKD","LU1430594728.SGD","LU2125154778.USD","LU2360032135.SGD","BMED","LU0320765646.SGD","LU1201861249.SGD","LU1941712264.USD","LU0203345920.USD","SG9999014575.USD","MRK","BK4559","IE00BLSP4452.SGD","LU1066051811.HKD","SG9999013999.USD","LU0477156953.USD","LU1974910355.USD","LGHT","LU1061106388.HKD","LU1023059063.AUD","LU1983299246.USD","IE00BN8TJ469.HKD","LU1093756325.SGD","TRUH","LU1066051498.USD","LU0234572021.USD","BK4007","LU0070302665.USD","SG9999001440.SGD","LU1934455863.HKD","BK4532","LU2461242641.AUD","SGXZ57979304.SGD","SG9999014542.SGD","IE0009355771.USD","LU2468319806.SGD","IE00BLSP4239.USD","LU0823416689.USD","LU0238689110.USD","LU0689626769.HKD","LU1923622614.USD","LU2491050071.SGD","LU2125909247.SGD","LU1035773651.USD","LU0124676726.USD","LU0861579265.USD","IE00BBT3K403.USD","LU2089984988.USD","SG9999015341.SGD","SG9999001176.USD","LU1066053197.SGD","BK4550","RXL","LU2361044949.HKD","LU0006306889.USD","LU2112291526.USD","GDOC","LU2361045086.USD","WDNA","LU0130102774.USD","LU1941712348.USD","BK4585","LU2491050154.USD","IE00B2B36J28.USD","LU0098860793.USD","LU0432979614.USD","LU1093756168.USD","LU2023250843.SGD","LU0965509283.SGD","SG9999002232.USD","LU1585245621.USD","LU1917777945.USD","BK4501","LU0265550359.USD","SG9999014567.USD","BK4533","XLV","LU0985320562.USD","IE00BJJMRZ35.SGD","PAWZ","LU1066051225.USD","LU0965509101.SGD","LU0106261372.USD","LU1989772923.USD","FHLC","LU1291159041.SGD","LU2361044865.SGD","IE00B4R5TH58.HKD","BK4588","FTXH","IE000M9KFDE8.USD","LU0266013472.USD","LU2125154935.USD","LU0965509010.AUD","LU1989771016.USD","LU2023250504.SGD","IE00BSNM7G36.USD","LU1069347547.HKD","LU1699723380.USD","IE00BJT1NW94.SGD","LU1037948897.HKD","SG9999002224.SGD","VHT","BK4516","LU2433249047.HKD","LU1116320901.HKD","BK4534","LU0203347892.USD","LU0211331839.USD","LU0965508806.USD","LU0648001328.SGD","PPH","LU2324357040.USD","BK4551","IHE","LU0130517989.USD","LU0058720904.USD","MRNX","LU1929549753.HKD","LU1162221912.USD","MRNA","IE00BFTCPJ56.SGD","IDNA","LU0320765489.SGD","LU2125909593.SGD","JDOC","BK4568","LU0980610538.SGD","LU0122379950.USD","BK4139","LU0208291251.USD","LU0289739699.SGD","LU0868494708.USD","LU1116320737.USD","LU2357627491.SGD","LU1037948541.HKD","LU1057294990.SGD","LU0265550946.USD","LU1571399168.USD","HRTS","LU2491049909.HKD","SG9999001176.SGD","GNOM","IE0002141913.USD","LU1934455194.USD","BK4548","LU1934455277.USD","SG9999015358.SGD","SG9999014559.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661057292","title":"美股醫療板塊創6月以來最佳周表現，mRNA抗癌疫苗突破提振市場","url":"https://stock-news.laohu8.com/highlight/detail?id=2661057292","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661057292?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 03:49","pubTimestamp":1787341783,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU1162221912.USD","LU1116320737.USD","HRTS","JDOC","LU0980610538.SGD","LU1037948897.HKD","LU2360032135.SGD","LU2125154778.USD","MRK","IXJ","LU1934455277.USD","RXL","LU0130102774.USD","LU2361045086.USD","LU0098860793.USD","BK4533","LU0689626769.HKD","LU0203347892.USD","TRUH","LU1093756168.USD","IE00B4R5TH58.HKD","LU2023250504.SGD","PAWZ","LU2357627491.SGD","LU1941712264.USD","LU1035773651.USD","FTXH","BMED","LU0058720904.USD","XLV","LU1571399168.USD","LU0234572021.USD","SG9999015341.SGD","LU2125154935.USD","LU0648001328.SGD","LU1941712348.USD","VHT","GDOC","PPH","IE00BJJMRZ35.SGD","LU1066051498.USD","IE00BLSP4239.USD","LU2468319806.SGD","IYH","LU1974910355.USD","LU0320765646.SGD","LU1066053197.SGD","FHLC","LU1093756325.SGD","IHE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661917672","title":"三名科學家在涉及滑石粉研究的誹謗訴訟中勝訴，該訴訟由強生公司提起","url":"https://stock-news.laohu8.com/highlight/detail?id=2661917672","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661917672?lang=zh_tw&edition=fundamental","pubTime":"2026-08-22 00:28","pubTimestamp":1787329711,"startTime":"0","endTime":"0","summary":"三名科学家在涉及滑石粉研究的诽谤诉讼中胜诉，该诉讼由强生公司提起Dietrich Knauth路透纽约8月21日-弗吉尼亚州的一位美国法官裁定，三名研究人员发表的研究将化妆品级滑石粉产品与间皮瘤联系起来，此举并不构成对强生公司的诽谤。三名被告均为从事病理学诊疗工作的医生，曾作为原告方专家在石棉诉讼中出庭作证。强生公司还起诉了发表2019年论文的科学家。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL4T44I0ZO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0426412945.USD","IXJ","TRUH","JDOC","IE00BSNM7G36.USD","BK4007","LU1894683264.USD","LU2468319806.SGD","MEDX","RXL","IE00B3T34201.USD","LU2456880835.USD","SGXZ57979304.SGD","IHE","IE0002270589.USD","IE000F7OJYX1.SGD","JNJ","LU2487616109.SGD","LU1121112475.USD","LU1894683348.USD","BK4550","LU0964807845.USD","LU1989771016.USD","LU0689472784.USD","LU2430703095.HKD","LU1032466523.USD","LU1551013425.SGD","LU1145028129.USD","LU1732800096.USD","IYH","LU2471134879.HKD","LU1983299246.USD","FHLC","LU2129689514.USD","VHT","FTXH","XLV","IE00BVYPNV92.GBP","BMED","LU1228905037.USD","LU0426417589.USD","IE00BBT3K403.USD","LU2602419157.SGD","IE0000B7K699.USD","PJP","LU1043141396.HKD","LU0345769128.USD","LU0432979614.USD","GDOC","LU0689626769.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661229152","title":"受癌症疫苗試驗數據影響，Moderna股價連續第三個交易日劇烈震盪","url":"https://stock-news.laohu8.com/highlight/detail?id=2661229152","media":"路透中文","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661229152?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 23:58","pubTimestamp":1787327905,"startTime":"0","endTime":"0","summary":"BUZZ-受癌症疫苗试验数据影响，Moderna股价连续第三个交易日剧烈震荡8月21日-** 莫德纳（Moderna）MRNA.O股价上涨14.5%，至152.60美元，收复了周四部分跌幅** 周五的反弹标志着受莫德纳和默克MRK.N周三公布的晚期癌症疫苗临床试验数据 (link) 影响，股价已连续第三个交易日出现剧烈波动** 周三，Moderna股价暴涨近177% (link)，周四则暴跌23.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL4S44I0Y8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0130102774.USD","LU0211331839.USD","IE00BJJMRZ35.SGD","LU1061106388.HKD","LU1989772840.SGD","LU1057294990.SGD","LU2468319806.SGD","IYH","BK4551","LU1571399168.USD","LU1989771016.USD","MRNY","LU1585245621.USD","LU0058720904.USD","BMED","WDNA","LU0208291251.USD","LU1035773651.USD","LU1037948897.HKD","SG9999001176.SGD","SG9999015358.SGD","LU0868494617.USD","IE00BFTCPJ56.SGD","LGHT","LU0648001328.SGD","IE000M9KFDE8.USD","IDNA","LU2106854487.HKD","LU1066051225.USD","LU2125909247.SGD","BK4585","LU0965508806.USD","LU0289739699.SGD","PAWZ","LU2023250843.SGD","IE00BLSP4452.SGD","BK4516","GDOC","LU0234572021.USD","LU0477156953.USD","MRK","HRTS","LU1201861249.SGD","LU2491050071.SGD","BK4588","LU2433249047.HKD","SG9999002232.USD","LU1974910355.USD","LU0203345920.USD","LU0124676726.USD","LU1430594728.SGD","VHT","JDOC","LU0265550946.USD","LU1066051498.USD","IE00B1BXHZ80.USD","LU2125909593.SGD","LU1066051811.HKD","BK4559","BK4550","LU2324357040.USD","RXL","LU0823416689.USD","LU1116320901.HKD","IE0009355771.USD","LU0965509010.AUD","LU0098860793.USD","LU1929549753.HKD","LU2461242641.AUD","SG9999001176.USD","SG9999002224.SGD","LU0070302665.USD","IE00BN8TJ469.HKD","MRNX","LU0432979614.USD","LU1941712264.USD","LU2125154935.USD","LU2360032135.SGD","IE00BJT1NW94.SGD","IE00B4R5TH58.HKD","IE00BSNM7G36.USD","LU1983299246.USD","LU2125154778.USD","LU1917777945.USD","BK4007","LU1037948541.HKD","LU2089984988.USD","LU0689626769.HKD","LU1941712348.USD","LU0320765489.SGD","LU0965509101.SGD","LU0106261372.USD","SG9999001440.SGD","SG9999014567.USD","LU1093756168.USD","FHLC","LU0861579265.USD","BK4532","LU0238689110.USD","LU2361045086.USD","LU0266013472.USD","IE00BBT3K403.USD","LU0985320562.USD","XLV","LU2361044865.SGD","LU0320765646.SGD","LU1069347547.HKD","LU0122379950.USD","LU1116320737.USD","LU2112291526.USD","SG9999013999.USD","LU0006306889.USD","IXJ","LU0265550359.USD","BK4139","LU1989772923.USD","GNOM","BK4568","IE00B2B36J28.USD","LU1934455277.USD","IHE","LU2491050154.USD","LU0868494708.USD","BK4501","LU1934455863.HKD","BK4533","LU0130517989.USD","TRUH","IE00BLSP4239.USD","LU1291159041.SGD","SG9999014559.SGD","LU1934455194.USD","SGXZ57979304.SGD","SG9999014575.USD","LU1066053197.SGD","LU0203347892.USD","LU1162221912.USD","LU2357627491.SGD","LU1093756325.SGD","BK4548","LU1923622614.USD","PPH","IE0002141913.USD","SG9999015341.SGD","FTXH","BK4534","MRNA","SG9999014542.SGD","LU0965509283.SGD","LU2491049909.HKD","LU0942090050.USD","LU1699723380.USD","LU0859254822.USD","LU0980610538.SGD","LU2023250504.SGD","LU1023059063.AUD","LU2361044949.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661729698","title":"默沙東(MRK.US)股價盤中上漲高達3.7%，突破周三創下的歷史高點。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661729698","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661729698?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 22:28","pubTimestamp":1787322483,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["GDOC","IXJ","LU1989772840.SGD","LU2023250504.SGD","LU1093756325.SGD","LU1037948897.HKD","BK4585","IE00BBT3K403.USD","LU0234572021.USD","LU0320765489.SGD","LU1923622614.USD","LU0124676726.USD","LU1066051225.USD","SG9999015358.SGD","LU1983299246.USD","VHT","LU1934455863.HKD","SG9999015341.SGD","BK4559","SG9999014559.SGD","IHE","LU0265550946.USD","LU2357627491.SGD","LU1989772923.USD","LU0477156953.USD","MRK","LU0006306889.USD","LU2106854487.HKD","SG9999002224.SGD","LU1934455194.USD","LU1571399168.USD","LU1917777945.USD","LU1066051498.USD","BK4550","LU2125909593.SGD","LU2023250843.SGD","LU1057294990.SGD","LU0965509101.SGD","LU2324357040.USD","IE00BJT1NW94.SGD","LU0130517989.USD","IE0009355771.USD","LU1035773651.USD","SG9999014575.USD","SGXZ57979304.SGD","SG9999001176.SGD","LU0965509010.AUD","LU0130102774.USD","LU1037948541.HKD","LU0211331839.USD","LU1066053197.SGD","TRUH","LU0070302665.USD","IE00BFTCPJ56.SGD","PPH","SG9999001176.USD","FTXH","SG9999014542.SGD","JDOC","IE00BLSP4239.USD","LU2491049909.HKD","LU1066051811.HKD","LU1201861249.SGD","LU0985320562.USD","LU2125909247.SGD","LU0980610538.SGD","LU0861579265.USD","LU2433249047.HKD","LU2089984988.USD","SG9999013999.USD","LU1934455277.USD","LU1061106388.HKD","BK4588","LU0238689110.USD","LU0098860793.USD","LU1585245621.USD","LU0265550359.USD","LU0289739699.SGD","LU1162221912.USD","LU0965508806.USD","BK4516","BK4533","BK4534","LU1941712348.USD","SG9999002232.USD","LU1929549753.HKD","LU1116320901.HKD","LU1116320737.USD","LU0058720904.USD","LU2491050071.SGD","XLV","LU1023059063.AUD","LU0266013472.USD","LU2491050154.USD","LU1291159041.SGD","LU2468319806.SGD","LU0823416689.USD","IE00BLSP4452.SGD","FHLC","LU1974910355.USD","IE0002141913.USD","LU2125154935.USD","LU2461242641.AUD","LU0106261372.USD","LU2360032135.SGD","LU2125154778.USD","LU1699723380.USD","IE00BSNM7G36.USD","RXL","LU0122379950.USD","LU1069347547.HKD","HRTS","LU0689626769.HKD","LU1093756168.USD","IE00B2B36J28.USD","IE00BN8TJ469.HKD","LU1989771016.USD","LU0965509283.SGD","LU0868494708.USD","LU2361044865.SGD","LU0942090050.USD","LU0320765646.SGD","IE000M9KFDE8.USD","LU1430594728.SGD","PAWZ","SG9999014567.USD","LU0859254822.USD","IE00B4R5TH58.HKD","LU0203347892.USD","LU0432979614.USD","LU1941712264.USD","IE00BJJMRZ35.SGD","LU2361045086.USD","LU2361044949.HKD","LU0208291251.USD","LU0648001328.SGD","LU0868494617.USD","LU2112291526.USD","IE00B1BXHZ80.USD","IYH","LU0203345920.USD","BMED","BK4007","SG9999001440.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661296351","title":"默沙東(MRK)股票8月21日盤中上漲3.41%：真相來了","url":"https://stock-news.laohu8.com/highlight/detail?id=2661296351","media":"TradingKey中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661296351?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 22:16","pubTimestamp":1787321766,"startTime":"0","endTime":"0","summary":"• 默沙东与莫德纳宣布其癌症疫苗的3期临床试验取得积极结果。\n• 在这一临床试验顺利达成里程碑后，多家主流券商上调了默沙东的股票评级。\n• 技术指标显示出买入信号，同时威廉指标（Williams %R）处于超买状态。","market":"sg","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/zh-hans/news/market-movers/262124811-market-movers-mrk-20260821","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0002141913.USD","SG9999014567.USD","LU1116320901.HKD","LU1989772840.SGD","LU1037948897.HKD","PAWZ","IE00BLSP4452.SGD","LU1974910355.USD","TRUH","BK4516","LU0689626769.HKD","LU1917777945.USD","LU0106261372.USD","LU0130102774.USD","LU1941712264.USD","BK4559","LU1066051811.HKD","LU1061106388.HKD","LU1989771016.USD","BK4534","LU1093756325.SGD","BK4533","LU2112291526.USD","LU0124676726.USD","IHE","MRK","LU1093756168.USD","LU1989772923.USD","LU0006306889.USD","LU2361044865.SGD","XLV","LU2324357040.USD","LU1923622614.USD","LU0265550359.USD","LU0211331839.USD","LU2433249047.HKD","LU2361044949.HKD","LU0648001328.SGD","BK4585","IXJ","LU0130517989.USD","IE00BJJMRZ35.SGD","SG9999001176.SGD","SG9999013999.USD","LU2491049909.HKD","LU1069347547.HKD","LU2089984988.USD","FHLC","LU2357627491.SGD","GDOC","IE00B2B36J28.USD","LU0058720904.USD","LU0965509101.SGD","SG9999001176.USD","LU1023059063.AUD","IE00B4R5TH58.HKD","LU2023250843.SGD","LU0859254822.USD","HRTS","IE00BJT1NW94.SGD","LU2023250504.SGD","LU0868494708.USD","IE00BLSP4239.USD","LU0477156953.USD","LU0070302665.USD","BK4007","LU1291159041.SGD","LU1699723380.USD","LU1571399168.USD","SG9999015358.SGD","LU1201861249.SGD","SG9999002224.SGD","LU1934455863.HKD","LU2106854487.HKD","LU0266013472.USD","LU0965509283.SGD","LU0868494617.USD","RXL","LU1116320737.USD","LU0823416689.USD","LU2491050071.SGD","LU1934455194.USD","BK4588","LU1430594728.SGD","LU2461242641.AUD","LU0320765646.SGD","LU0098860793.USD","IE000M9KFDE8.USD","IE00BN8TJ469.HKD","VHT","LU1037948541.HKD","LU0861579265.USD","SGXZ57979304.SGD","LU1066051498.USD","LU1066051225.USD","LU2125909247.SGD","LU1934455277.USD","SG9999014542.SGD","FTXH","LU1035773651.USD","LU1066053197.SGD","LU0985320562.USD","LU0965509010.AUD","LU0289739699.SGD","LU1929549753.HKD","LU0122379950.USD","IYH","LU1057294990.SGD","BMED","LU0265550946.USD","JDOC","LU0432979614.USD","LU1983299246.USD","LU2468319806.SGD","LU0942090050.USD","IE00B1BXHZ80.USD","LU0980610538.SGD","BK4550","SG9999001440.SGD","SG9999014575.USD","LU0238689110.USD","LU1162221912.USD","PPH","LU2361045086.USD","LU2125154778.USD","IE00BFTCPJ56.SGD","LU0208291251.USD","LU2360032135.SGD","SG9999014559.SGD","LU0320765489.SGD","LU0203345920.USD","LU1941712348.USD","IE00BSNM7G36.USD","LU0234572021.USD","LU0965508806.USD","LU2125909593.SGD","LU0203347892.USD","IE00BBT3K403.USD","LU2125154935.USD","IE0009355771.USD","SG9999002232.USD","SG9999015341.SGD","LU2491050154.USD","LU1585245621.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661298881","title":"上海萊士：子公司蛋白C臨床試驗申請獲受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2661298881","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661298881?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 20:18","pubTimestamp":1787314710,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBJ","PSYK","IBBQ","MDTX","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661267717","title":"華北製藥：金坦公司六價疫苗獲准開展臨床試驗","url":"https://stock-news.laohu8.com/highlight/detail?id=2661267717","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661267717?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 19:36","pubTimestamp":1787312177,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","IBBQ","PSYK","IBBJ","BMED"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661426475","title":"中國生物製藥(01177)：TQF6422注射液「ActRII A/B單抗」臨床試驗申請獲NMPA批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2661426475","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661426475?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 18:35","pubTimestamp":1787308504,"startTime":"0","endTime":"0","summary":"智通财经APP讯，中国生物制药 发布公告，本集团附属公司正大天晴药业集团股份有限公司自主研发的国家1类创新药TQF6422注射液已获得中国国家药品监督管理局药品审评中心批准开展临床研究，拟用于成人肥胖患者，或超重且合并至少一种体重相关合并症患者的体重管理。因此，靶向ActRII通路具有同步改善脂肪量与瘦体重的潜力。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483419.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BMED","IE00BZ08YT58.USD","IBBQ","IBBJ","MDTX","BK1521","PSYK","01177","BK1589","IE00BZ08YS42.EUR","IE00BZ08YR35.GBP","BK1515","HK0000165453.HKD","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661266963","title":"我武生物：貓毛膜劑獲治療用生物製品1類臨床試驗批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2661266963","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661266963?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 17:10","pubTimestamp":1787303425,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBBQ","BMED","PSYK","IBBJ","MDTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661325043","title":"百利天恒依據首例給藥臨床試驗確認17億元里程碑收入，BMS尚未打款缺少實質性臨床終點數據","url":"https://stock-news.laohu8.com/highlight/detail?id=2661325043","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661325043?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 15:08","pubTimestamp":1787296080,"startTime":"0","endTime":"0","summary":"百利天恒，于2023年1月登陆上交所科创板。即使抛开上述的勾稽关系断裂不谈，该笔17.76亿元里程碑收入的确认时点同样令人费解，或涉嫌利用会计估计的自由裁量权提前确认收入以粉饰报表，或误导投资者。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-21/doc-inipaenp6496930.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MDTX","IBBJ","688506","BMED","91194","PSYK","BMS","BK0239","IBBQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661525102","title":"高露潔棕欖印度公司任命Kenvue高管擔任董事總經理兼首席執行官","url":"https://stock-news.laohu8.com/highlight/detail?id=2661525102","media":"路透中文","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661525102?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 12:20","pubTimestamp":1787286030,"startTime":"0","endTime":"0","summary":"更新 1-高露洁棕榄印度公司任命Kenvue高管担任董事总经理兼首席执行官全文包含详细更新内容路透8月21日-高露洁-棕榄印度公司于周五任命Kenvue公司高管马尼什·阿南达尼为公司董事总经理兼首席执行官，该任命将于9月28日生效。纳拉辛汉曾担任高露洁-棕榄印度公司董事总经理兼首席执行官近四年，此前在消费品行业担任过高级管理职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL4T44I097:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1121112475.USD","LU1244550494.USD","RXL","FHLC","LU2430703178.SGD","IE000WAW04H5.SGD","LU1280957306.USD","BK4581","XLV","LU1074936037.SGD","LU1236620834.HKD","LU0323591593.USD","BMED","IE00B42XCP33.USD","IE00BJT1NW94.SGD","LU1145028129.USD","VHT","IXJ","GDOC","PJP","TRUH","FTXH","SG9999001176.USD","JDOC","BK4588","LU0070302665.USD","KVUE","BK4568","JNJ","LU0234572021.USD","LU2430703251.USD","IE000F7OJYX1.SGD","LU2471134879.HKD","LU0072461881.USD","LU2592432038.USD","LU1261432733.SGD","IHE","LU2125154778.USD","CL","LU2108987350.USD","IYH","BK4534","BK4504","GLAM","LU1732799900.SGD","MEDX","IE000M9KFDE8.USD","LU0787776722.HKD","IE00BVYPNV92.GBP","RSPS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661251135","title":"一品紅(300723.SZ)子公司創新藥APH03867片臨床試驗申請獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2661251135","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661251135?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 11:48","pubTimestamp":1787284128,"startTime":"0","endTime":"0","summary":"智通财经APP讯，一品红(300723.SZ)发布公告，近日，公司全资子公司广州一品红制药有限公司自主研发的创新药物APH03867片的药物临床试验申请已获得国家药品监督管理局批准，并收到《药物临床试验批准通知书》，将于近期开展临床试验。据悉，APH03867片是由公司自主研发的一种新型口服、非肽类小分子URAT1抑制剂(全称：Urate Transporter 1，中文译为：尿酸转运蛋白1)抑制剂，通过抑制肾脏中URAT1的活性，阻断尿酸在肾小管的重吸收，增加尿酸排泄，达到有效降低血尿酸的效果，可用于改善高尿酸血症和痛风症状。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1483126.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["MEDX","BMED","159992","300723","IBBQ","LNGR","MDTX","BK0239","BK1161","06978","PSYK","BK1574","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661519922","title":"一品紅：子公司APH03867片臨床試驗獲批","url":"https://stock-news.laohu8.com/highlight/detail?id=2661519922","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661519922?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 11:44","pubTimestamp":1787283894,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MDTX","BMED","PSYK","IBBQ","IBBJ"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":10,"totalSize":200,"code":"91000000","status":"200"}]}}